A comparative study of herbal formulation and standard drug

A standard controlled clinical study of Varuna shigru guggulu and Bala taila matra basti in the management of mootraghata w.s.r to benign prostatic hyperplasia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/10/006279

Enrollment

100

Registered

2015-10-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- BPH

Interventions

Intervention1: Group A trial group Ayurved formulation: Group A Varuna shigru guggulu 500 mg TID orally for 30 days and Bala taila matra basti 60 ml OD for 30 days Intervention2: Group B cap Urimax:

Eligibility

Inclusion criteria

Inclusion criteria: Classical signs and symptoms of mootraghata(BPH)

Exclusion criteria

Exclusion criteria: Age below 40 years Uncontrolled cases of DM, HTN Positive cases of HIV, HbsAg ,VDRL

Design outcomes

Primary

Measure	Time frame
The improvement will be assessed on the basis of international prostate symptom score Average urine flow rate Prostate size Post voidal residual urine volume Timepoint: The improvement will be assessed on the basis of international prostate symptom score Average urine flow rate Prostate size Post voidal residual urine volume	—

Secondary

Measure	Time frame
The improvement will be assessed on the basis of international prostate symptom score Average urine flow rate Prostate size Post voidal residual urine volume Timepoint: 30 days	—

Countries

India

Contacts

Public ContactProf S K Gupta

IPGT RA

drtsdudhamal@gmail.com94-28-671939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026